BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 10706740)

  • 21. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
    Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
    Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD40-CD154 pathway blockade requires host macrophages to induce humoral unresponsiveness to pig hematopoietic cells in baboons.
    Bühler L; Alwayn IP; Basker M; Oravec G; Thall A; White-Scharf ME; Sachs DH; Awwad M; Cooper DK
    Transplantation; 2001 Dec; 72(11):1759-68. PubMed ID: 11740385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
    J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloantigenic stimulation bypasses CD28-B7 costimulatory blockade by an interleukin-2-dependent mechanism.
    Blazevic V; Pinto LA; Trubey CM; Shearer GM
    J Leukoc Biol; 2000 Jun; 67(6):817-24. PubMed ID: 10857854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.
    Xu H; Yan J; Huang Y; Chilton PM; Ding C; Schanie CL; Wang L; Ildstad ST
    Blood; 2008 Mar; 111(6):3266-75. PubMed ID: 17827394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
    Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
    Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity.
    Vermeiren J; Ceuppens JL; Van Ghelue M; Witters P; Bullens D; Mages HW; Kroczek RA; Van Gool SW
    J Immunol; 2004 May; 172(9):5371-8. PubMed ID: 15100277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete blockade of B7 family-mediated costimulation is necessary to induce human alloantigen-specific anergy: a method to ameliorate graft-versus-host disease and extend the donor pool.
    Gribben JG; Guinan EC; Boussiotis VA; Ke XY; Linsley L; Sieff C; Gray GS; Freeman GJ; Nadler LM
    Blood; 1996 Jun; 87(11):4887-93. PubMed ID: 8639863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
    Front Immunol; 2019; 10():306. PubMed ID: 30863408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation.
    Bosticardo M; Ariotti S; Losana G; Bernabei P; Forni G; Novelli F
    Eur J Immunol; 2001 Sep; 31(9):2829-38. PubMed ID: 11536182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.
    Griggs ND; Agersborg SS; Noelle RJ; Ledbetter JA; Linsley PS; Tung KS
    J Exp Med; 1996 Mar; 183(3):801-10. PubMed ID: 8642284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cellular immune responses to encapsulated porcine islet xenografts by simultaneous blockade of two different costimulatory pathways.
    Safley SA; Kapp LM; Tucker-Burden C; Hering B; Kapp JA; Weber CJ
    Transplantation; 2005 Feb; 79(4):409-18. PubMed ID: 15729166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of CD4 T cell changes in murine AIDS is dependent on costimulation and involves a dysregulation of homeostasis.
    Yen MH; Lepak N; Swain SL
    J Immunol; 2002 Jul; 169(2):722-31. PubMed ID: 12097374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting T cell costimulation in autoimmune disease.
    Stuart RW; Racke MK
    Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance.
    Silver PB; Hathcock KS; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(9):5041-7. PubMed ID: 11046033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costimulatory molecules are active in the human xenoreactive T-cell response but not in natural killer-mediated cytotoxicity.
    Tadaki DK; Craighead N; Saini A; Celniker A; Burkly LC; Lee KP; Chute JP; Harlan DM; Kirk AD
    Transplantation; 2000 Jul; 70(1):162-7. PubMed ID: 10919595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo.
    Yuan X; Salama AD; Dong V; Schmitt I; Najafian N; Chandraker A; Akiba H; Yagita H; Sayegh MH
    J Immunol; 2003 Mar; 170(6):2949-55. PubMed ID: 12626546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
    Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
    J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.